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1 Introduction
High levels of glycosylated hemoglobin (HbAj) are
observed in patients suffering from poorly control-
led diabetes mellitus [19]. Measurement of glyco-
sylated hemoglobin has proved to be a valuable
clinical tool of long-term diabetes control since it
represents an objective and reliable indicator of
overall blood glucose concentrations during the
previous eight weeks [3, 18].
HbAj comprises three main fractions la, Ib and
Ic. HbAlc is formed through non-enzymatic con-
densation of a molecule of the aldose sugar glucose
with the amino terminal valine of the hemoglobin
jß-chain, and it is actually the amount of HbA lcin
its stable ketoamine form which reflects the inte-
grated glycemia of the previous two months and
makes possible the use of HbAjL measurement as a
means of glucose regulation assessment [9].
HbAla contains hemoglobin adducts of glucose-6-
phosphate and fructose-1,6-diphosphate [13], and
HbAlb is probably a deamidation product of
hemoglobin [10].
The HbAj elevation in diabetic blood samples is
only related to the HbAlc component, whereas
the concentrations of HbAla and HbAlb do not
differ in non-diabetic and diabetic subjects, as
CASTAGNOLA et al. [2] demonstrated recently
by macrochromatographic fractionation of HbAl
from non-diabetic and diabetic subjects. The latter
evidence implies that HbA! assay - without sepa-
rated measurement of the HbAlc component - is
a clinically satisfactory method of glucose regula-
tion monitoring.
HbAlc, as a stable ketoamine is derived by rear-
rangement from a labile reversible Schiff base
adduct [6] whose content depends on short-term
blood glucose variations. Once the ketoamine has
formed, the condensation product of human adult
hemoglobin and glucose remains irreversible during
the life span of the red cells [1, 4]. Thus, blood
glucose leaves its specific chemical engramme on
the hemoglobin molecule.
Non-enzymatic glycosylation does occur also in
long half-life proteins other than hemoglobin and
can theoretically lead to alterations of their struc-
tural and functional properties. These alterations
could play a role in the genesis of diabetic compli-
cations such as nephropathy, vasculopathy or
cataracts.
The main objectives of the present study are to
clarify
a) what values of glycosylated hemoglobin are to
be encountered in untreated gestational diabetes
during late pregnancy and how these values do
differ from those in non-diabetic mothers, and
b) whether and to what extent measurements of
glycosylated hemoglobin are suitable for the
diagnosis or diagnostic exclusion of gestational
diabetes. In addition, the neonatal outcome from
the gestational diabetics — after appropriate treat-
ment of their metabolic disturbance — is compared
with that from the non-diabetic mothers.
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Tab. I. Anthropological data on the women examined
Age
(years)
Non-diabetic mothers with normal weight neonates (Group I)
Non-diabetic mothers with macrosomic neonates (Group II)
Gestational diabetic women (Group III)
25.8
26.8
30.8
+
±
±
4.9
5.7
5.6
Body
prior
(kg)
weight*
to last pregnancy
59 ± 7
60 ± 7
68 ± 12
Body
height
(cm)
165 ±
165 ±
163 ±
7
7
7
* Body weight prior to last pregnancy was presented according to the personal statements of the women. — Data
presented: χ ± s.d.
2 Patients, materials and methods
2.1 Subject groups
Determinations of glycosylated hemoglobin were
done in 153 women:
Group I: 69 non-diabetic mothers who were
delivered of normal weight infants at
term.
Group II: 33 non-diabetic mothers who were
delivered of macrosomic infants at
term.
Group HI: 51 gestational diabetics in the 3rd
trimester before the onset of the
diabetes therapy.
Table I shows some anthropological data on the
women examined. It should be noted that the
gestational diabetics (Group III) were on the
average 4 to 5 years older and 8 to 9 kg heavier
than the non-diabetic women. In this group, one
out of five suffered from obesity, i.e. an over-
weight of at least 20% above normal. In contrast,
in the non-diabetics examined (Group I and II),
only 4% were obese prior to and during preg-
nancy. Normal birthweight of the infants was
defined as being between the 10th and 90th per-
centiles for gestational age according to the birth-
weight curves of NiCKL [15] which describe the
relative frequency of birthweight by week of
gestation for the German population. The macro-
somic infants had a birthweight above the 90th
percentile and almost all of them weighed more
than 4000 g.
2.2 Oral glucose tolerance test
The assessment of glucose regulation was done
during the 3rd trimester by means of the oral
glucose tolerance test (OGTT, 100g). The tests
commenced at 8 o'clock in the morning after
overnight fasting. The glucose concentration was
measured in the plasma of capillary blood using a
glucose oxidase method in a Glucose Analyzer II,
Beckman. To differentiate the non-diabetic cases
from the gestational diabetic cases, the blood
glucose criteria of Q'SULLIVAN and MAHAN [17]
were applied; they were modified for the enzy-
matic glucose assay in capillary plasma. A patient
was diagnosed as diabetic if at least two glucose
values exceeded the following limits: 0 hours
IpOmg/lOOml, 1 hour 190mg/100ml, 2 hours
170mg/100 ml.
Figure 1 gives an overall representation of the
plasma glucose levels measured during oral glucose
tolerance test in our 3 subject groups.
τ
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Fig. 1. Glucose levels during oral glucose tolerance test
(100 g). — Glucose concentrations were measured in
plasma of capillary blood_ by-means of a glucose oxidase
method. Data presented:-x:.i'2 s:d'.' ·
Group I: continuous -line; Group II: broken line; Group III:
dotted line.
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2.3 Samples
For glycosylatcd hemoglobin assay, venous blood
anticoagulated with EDTA was used. Blood was
withdrawn early in the morning after overnight
fasting. In Groups I and II sample collection was
done on the first or second day after delivery, in
Group III at the latest 4 weeks prior to delivery
and before onset of the diabetes therapy. If not
freshly processed, the samples were stored in a
refrigerator at 2 to 4°C. All samples were pro-
cessed within 48 hours after withdrawal.
2.4 Assay of glycosylated hemoglobin (HbA i)
Glycosylatcd hemoglobin was determined by
cation-exchange chromatography in small dispos-
able columns, 0.9 χ 10 cms. (BOEHR1NGER, Mann-
heim). We chromatographed the hcmolysates of
unwashed erythrocytes on the ion-exchange resin
(Biorex 70 or Amberlite IRC 50, l g per column)
equilibrated with phosphate buffer, 40 mmol/L,
pH6.7. After elution with the phosphate buffer
of the "fast" Chromatographie fraction (HbA!),
we compared the absorbance at 415 nm of the fast
fraction with the absorbance of the second frac-
tion - containing the "other", i.e. non-glyco-
sylated hemoglobin, which was eluted by a sodium
chloride solution, 400 mmol/L. Applying a simple
mathematical equation, from the absorbances of
the two Chromatographie fractions the percentage
of glycosylated hemoglobin in relation to total
hemoglobin could be easily calculated.
All chromatographies were made at a regulated
room temperature of 23 °C. Samples and solutions
used were equilibrated at this temperature prior to
chromatography. In addition the column tempera-
ture was stabilized with a temperature-controlled
water jacket at 23 °C.
To ensure the validity of the results, in each
Chromatographie set of unknown samples a
commercial control hemolysate with known
content of glycosylated hemoglobin ("HbA,
Control normal", BOEHRINGER, Mannheim) was
run. The intra-assay coefficient of variation for the
method was 1.9% (n = 6), the inter-assay coeffi-
cient of variation amounted to 4.7% (n = 17) in
the range of 6.8% and 7.5% of HbAj.
3 Results and comments
3.1 Glycosylated hemoglobin in the 3 subject
groups
Table II shows the accumulated values of glyco-
sylated hemoglobin to be encountered in the
3 subject groups.
The mean HbAj values from the non-diabetic
mothers with normal weight neonates (Group I)
and from the non-diabetic mothers with macro-
somic neonates (Group II) are very similar to each
other and amount to 6.51% and 6.59% respec-
tively. There is no statistically significant correla-
tion between the HbAj values and the neonatal
birth weights.
Gestational diabetics prior to specific therapy
(Group III) demonstrate a mean HbA! value of
7.11%. The HbA! values from the gestational
diabetics differ significantly from those obtained
in the two non-diabetic subject groups: Group I vs.
Group III, χ2 = 16.92, p < 0.001; Group II vs.
Group III, χ2 = 12.23, p < 0.001, 1 degree of
freedom.
Tab. II. Accumulated values of HbAj in the three subject groups
Number of Giycosylated hemoglobin (%)
patients
examined Mean ± s.d. Mean - 2 s.d. Mean + 2 s.d. Min.-Max.
Non-diabetic mothers
with normal weight neonates
Non-diabetic mothers
with macrosomic neonates
Gestational diabetics
during the third trimester
69
33
51
6.51
6.59
7.11
±0.46
±0.42
±0.56
5.59
5.75
5.99
7.43
7.43
8.23
5.31-7.73
5.73-7.49
6.03-8.43
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Figure 2 depicts the distribution of the individual
HbAl values in the three groups investigated.
Within each group a considerable scatter of the
measured values can be recognized. More impor-
tant, there is a vast overlapping of the HbAj values
from the non-diabetic mothers and the gestational
diabetics. This implies that — on the basis of one
or more HbAj values situated in the area of over-
lapping — the physician will not readily be able to
differentiate between a non-diabetic pregnancy
and another one complicated by gestational
diabetes.
In contrast, HbA! values above or below the 95%
confidence limits for the appropriate metabolic
groups are of high diagnostic significance. An indi-
vidual HbAx value above 7.4% (x + 2 s.d. for
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Fig. 2. Individual HbAj values in the three subject groups.
Group I: non-diabetic mothers with normal weight
neonates;
Group II: non-diabetic mothers with macrosomic neo-
nates;
Group III: gestational diabetic mothers in the 3rd
trimester prior to diabetes therapy.
Group I) or below 6.0% (x - 2 s. d. for Group III)
will prove or exclude with a high degree of proba-
bility the existence of gestational diabetes. This is
valid if there are no severe concomitant diseases in
the pregnant woman which could alter the rate of
HbAj (for instance hemolytic anemia, renal insuf-
ficiency, pre-gestational overt diabetes mellitus)
and she did not receive a prolonged therapy with
agents known to cause hyperglycemia (sympathi-
comimetic agents, thiazide diuretics, cortico-
steroids etc.) before HbAj assay.
3.2 Neonatal outcome in the 3 subject groups
Table III presents clinical data on the neonates
from the mothers examined.
The macrosomic neonates from non-diabetic
mothers had an average overweight of almost
1 kg compared with that of their normal weight
counterparts. The rate of delivery by cesarean
section in the macrosomic group II was twice as
high as that in Group I. As judged by the SALING
score [20] recorded 5 minutes after delivery, the
postpartum status of the macrosomic infants was
just as good as that of the normal weight infants
of Group I. Their mean plasma glucose concentra-
tion measured one hour after delivery was slightly
lower than that in the infants of Group I.
In the neonates of our gestational diabetics —
appropriately treated — the average birthweight
amounted to 3405 g and was 150 g higher than
that in Group I. Their mean plasma glucose con-
centration recorded one hour after delivery was
the same as that in the macrosomic infants of
Group II, i.e. 49 mg/100 ml. In 10 of the infants
investigated however, hypoglycemias with plasma
glucose levels below 40 mg/100 ml were observed.
The postpartum status of the neonates from the
gestational diabetic women was nearly as good as
that of the infants from the non-diabetic mothers.
— In this connection it must be emphasized that
the gestational diabetics received a closely con-
trolled therapy with appropriate diet, and in some
cases with additional insulin injections. Taken as a
whole, the infants of the gestational diabetics did
not suffer serious impairment caused by the mater-
nal metabolic disorder, provided it was treated in
time and consistently.
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Tab. III. Clinical data on the neonatal outcome in the three subject groups
Birth Placental SALING score Plasma glucose Vaginal Cesarean
weight weight 5 min. p. p. Ihr. p.p. delivery section
(g) (g) (points) (mg/100ml) (%) (%)
Normal weight neonates
of non-diabetic mothers 3260 ± 268 617 ±110 10.9
Macrosomic neonates
of non-diabetic mothers 4172 ± 142 771 ± 114 11.0
Neonates of gestational
diabetic mothers 3405 ± 519 641 ± 139 10.6
56 ±14 97.1 2.9
49 ±11 93.5 6.5
49 ± 19 93.4 6.6
The scoring criteria of SALING [20] for the assessment of the postpartum status are similar to those of APGAR.
"Placental weight'' includes the weight of the membranes and of the placenta-adherent proportion of the cord. - Data
presented: χ ± s.d.
The ratios between placental weight: neonatal
weight in the non-diabetic groups and the gesta-
tional diabetic group were virtually identical:
Group I 0,19, Group II 0,18, Group III 0,19.
4 Discussion
In the present study the quantity of glycosylated
hemoglobin in non-diabetic mothers with normal
OGTT during late pregnancy and normal weight
offspring, (Group I) was 6.51 ±0.46% of total
hemoglobin. GAIN et al. [5] using an ion-exchange
Chromatographie assay very similar to ours,
demonstrated that HbAx in non-pregnant persons
with normal OGTT amounted to 6.45 ±0.62%.
Obviously, there is no appreciable difference
between the HbAl levels in pregnant and non-preg-
nant subjects with normal glucose regulation.
The upper normal limit of HbAl in our non-
diabetic mothers with normal weight offspring was
7.43 % (x + 2 s. d.)· HbAx values beyond this 95 %
confidence limit must be regarded incompatible
with normal glucose regulation. HbAj values
between 6.97% (x + 1 s.d.) and 7.43 % (x + 2 s.d.)
— or grossly spoken, above 7% and below 7.4% —
lie over the upper 70 % confidence limit of non-
diabetics and are therefore suspected of impaired
glucose tolerance or gestational diabetes.
As mentioned above, there were only slight and
insignificant differences between the mean values
and standard deviations for glycosylated hemo-
globin in non-diabetic mothers with macrosomic
neonates (Group II) and those in non-diabetic
mothers with normal weight infants (Group I).
The proportion of glycosylated hemoglobin to
total hemoglobin is significantly increased in overt
diabetes as a result of prolonged hyperglycemia. In
principle, the same is partially valid in gestational
diabetes, as could be shown in this paper. How-
ever, when looking more closely at the individual
HbAj values determined in the gestational diabetic
group, only 29% of them (15 out of 51) are
situated above HbAx 7.4% and thus definitely
pathological. Above HbAx 7.0% - the 70% con-
fidence limit and "warning limit" of Group I —
there are more than a half of the HbAx values
determined in the gestational diabetic group
(26 out of 51). Notably, almost half of the HbAi
values determined in untreated gestational diabetes
(25 out of 51) lies below the HbAx of 7% and are
for this reason undistinguishable from the "non-
diabetic" HbAj values, an observation which
evidently confines the usefulness of HbAj deter-
minations for diagnosing prolonged pregnancy-
related disorders of glucose regulation (Fig. 3).
Under these circumstances, in the majority of
cases with suspected gestational diabetes, HbAt
assay cannot simply replace the classical oral
glucose tolerance test to make the diagnosis. As a
rule, the two tests must be complementarily
applied for diagnostic ascertainment or exclusion
of gestational diabetes.
Since the individual level of glycosylated hemo-
globin is a rather inert and slowly changing para-
meter, HbAj values measured in maternal blood
samples withdrawn a few days after delivery are
J. Perinat. Med. 12 (1934)
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Glycosylated Hemoglobin
(%)
9 r π 9
Fig. 3. Mean values of HbAj with one or two standard
deviations in three subject groups. The shaded areas
represent the 70% and 95% confidence ranges for
Group I. Note the overlapping in the HbAj values of
non-diabetic groups I, II with those of the gestational
diabetic Group III. HbAj values above 7.4% - i.e. the
upper 95 % confidence limit of the non-diabetic mothers
— must be regarded as abnormal.
virtually equal to those obtained during the last
week before delivery. For that reason postpartum
HbAj values from mothers of macrosomic infants
may be of clinical interest in the subsequent diag-
nosis of a previously unsuspected and undetected
diabetes. The knowledge of a gestational diabetes
can be important for,the mother with regard to
the proper management in case of a future preg-
nancy, which would in all probability be com-
plicated by gestational diabetes again.
For the time being, HbAj assay by means of
miniaturized cation-exchange chromatography
columns, based on the work of TRIVELLI et al.
[23], is the method of choice in clinical use [11,
14, 16]. Since measurements of HbAl can now be
carried out accurately, precisely and promptly, they
are a useful tool in diagnosing and monitoring
diabetes mellitus of all types. Recently HbAt
assays have also been applied for detection of
impaired glucose tolerance in non-pregnant patients
[5, 7, 24].
The present paper attempts to show the possibil-
ities and limitations in diagnosing gestational dia-
betes by quantitation of glycosylated hemoglobin.
In order to draw the proper medical conclusions
from the HbAj values obtained from the inter-
mingling zones of normal glucose regulation in
pregnancy and gestational diabetes, a high degree
of reliability of the measurements is demanded. To
avoid erroneously high HbA! readings caused by
the labile aldimine fraction [8], blood samples
should be obtained after overnight fasting. They
should be stored for no longer than 3 days at
23°, 2 to 4° or -20°C, until their processing
[21, 22], because the ion-exchange methods are
associated with a marked increase in HbA! values
after prolonged sample storage [12]. Another
important source of incorrect HbA! results is
chromatography at different temperatures.
On observance of some intrinsic premisses, HbAl
assay can be used as a suitable additional chemical
indicator in the diagnostic confirmation or exclu-
sion of gestational diabetes.
Summary
Glycosylated hemoglobin (HbAx) was determined in
three subject groups: 69 non-diabetic mothers who were
delivered of normal weight infants at term (Group I),
33 non-diabetic mothers who were delivered of macro-
spmic infants (>4000g) at term (Group II), 51 gesta-
tional diabetics in the 3rd trimester - before onset of the
diabetes therapy (Group III). In all three groups diag-
nostic assessment of glucose regulation was done by
means of the oral glucose tolerance test during the 3rd
trimester. Glycosylated hemoglobin was assayed by
cation-exchange chromatography in small disposable
columns.
The mean values and standard deviations of HbA! were
6.51 ± 0.46% in Group I, 6.59 ± 0.42'% in Group II and
7.11 ± 0.56% in Group HI. Between the HbAt values of
Group III (gestational diabetes) on the one hand and
J. Perinat. Med. 12 (1984)
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those of the non-diabetic groups I and II on the other,
there were highly significant differences (p < 0.001;
x
2
-test).
HbAj values above 7.4 % - i.e. above + 2 s. d. of HbA!
in the non-diabetic mothers - were with 95 % probability
abnormal and indicative of gestational diabetes. HbAj
values between 7.0% and 7.4% were suspected of im-
paired glucose tolerance and gestational diabetes respec-
tively.
Between the HbAj levels in the non-diabetic groups and
those in the gestational diabetic group there was a vast
zone with overlapping values. HbAj data situated in this
transitional area could be found both in non-diabetic sub-
jects and also in those with abnormal glucose regulation.
HbAj values below 6.0% excluded gestational diabetes or
otherwise impaired glucose tolerance with a high degree
of probability.
As to the neonatal outcome, there were no remarkable
differences in the postpartum status of the three groups
investigated. The macrosomic infants of Group II were on
the average 1 kg heavier than the normal weight infants of
Group I. Their rate of cesarean section was twice as high
as that in Group I. In the gestational diabetic group the
average neonatal birthweight was 150 g higher than that
of the normal weight infants of non-diabetic mothers. The
infants of the gestational diabetic women showed an
increased tendency to develop moderate postpartual
hypoglycemias. It is noteworthy that the non-selected
gestational diabetic women in our study were on the aver-
age 8 to 9 kgs havier and 4 to 5 years older than their
non-diabetic counterparts. They received a closely con-
trolled diabetes therapy during the 3rd trimester of preg-
nancy.
Keywords: Birthweight, gestational diabetes, glucose tolerance, glycosylated hemoglobin, HbAj, macrosomia, neo-
natal outcome, oral glucose tolerance test.
Zusammenfassung
Glykosyliertes Hämoglobin (HbAj), Glukosetoleranz und
Neugeborene von gestationsdiabetischen und nicht-diabe-
tischen Müttern
Glykosyliertes Hämoglobin (HbA!) wurde bei drei Pro-
bandengruppen bestimmt: 69 nicht-diabetische Mütter,
die von normalgewichtigen Kindern am Termin entbun-
den wurden (Gruppe I), 33 nicht-diabetische Mütter, die
von makrosomen Kindern (> 4000 g) am Termin entbun-
den wurden (Gruppe II) und 51 Gestationsdiabetikerin-
nen im 3. Trimenon - vor Beginn der Diabetestherapie
(Gruppe III). Die Bewertung der Glukoseregulation wurde
in den drei Gruppen mit Hilfe des oralen Glukosetoleranz-
Tests (100g) im 3. Trimenon vorgenommen. Das glyko-
sylierte Hämoglobin wurde mittels Kationen-Austausch-
chromatographie in kleinen Kunststoffsäulen unter-
sucht.
Die Mittelwerte und Standardabweichungen von HbAj
betrugen 6,51 ±0,46% in Gruppe I, 6,59 ±0,42% in
Gruppe II und 7,11 ± 0,56 % in Gruppe III. Zwischen den
HbAj-Werten dar Gruppe III (Gestationsdiabetes) einer-
seits und jenen der nicht-diabetischen Gruppen I und II
andererseits bestanden statistisch signifikante Differenzen
(p<0,001;x2-Test).
HbArWerte über 7,4 % - d.h. über (x + 2 s.d.) HbA der
nicht-diabetischen Gruppen I und II - waren mit 95%
Wahrscheinlichkeit abnorm und wiesen auf einen Gesta-
tionsdiabetes hin. HbAj-Werte zwischen 7,0 und 7,4%
waren auf eine herabgesetzte Glukosetoleranz bzw. Gesta-
tionsdiabetes verdächtig.
Zwischen den Hb A -Werten der nicht-diabetischen Grup-
pen und denen der gestationsdiabetischen Gruppen gab es
einen weiten Bereich von überlappenden Werten. In
diesem Übergangsbereich gelegene HbA -Daten konnten
sowohl bei den nicht-diabetischen Frauen wie auch bei
jenen mit Gestationsdiabetes gefunden werden.
HbA]-Werte unter 6,0% schlössen einen Gestations-
diabetes oder eine anders entstandene Beeinträchtigung
der Glukosetoleranz von längerer Dauer mit hoher Wahr-
scheinlichkeit aus.
Was die Neugeborenen betrifft, bestanden keine nennens-
werten Unterschiede hinsichtlich ihres post-partum-Status
in den drei untersuchten Gruppen. Die makrosomen
Kinder der Gruppe II waren durchschnittlich l kg schwe-
rer als die normalgewichtigen Kinder der Gruppe I. Ihre
Rate der Schnittentbindungen war doppelt so hoch wie
jene in Gruppe I. In der Gruppe der gestationsdiabe-
tischen Frauen war das durchschnittliche kindliche
Geburtsgewicht ca. 150 g höher als das der normalgewich-
tigen Kinder von nicht-diabetischen Müttern. Die Kinder
der Gestationsdiabetikerinnen zeigten eine vermehrte
Tendenz zu postpartualen Hypoglykämien mäßigen
Grades. Es ist bemerkenswert, daß die nicht-selektierten
gestationsdiabetischen Frauen in unserer Studie im Durch-
schnitt 8 bis 9 kg schwerer und 4 bis 5 Jahre älter waren
als die nicht-diabetischen Frauen. Sie erhielten während
des 3. Schwangerschaftstrimenons eine intensiv über-
wachte Diabetestherapie.
Schlüsselwörter: Geburtsgewicht, Gestationsdiabetes, Glukosetoleranz, glykosyliertes Hämoglobin, HbAj, Makrosomie,
Neugeborene, oraler Glukosetoleranz-Test.
Resume
Hemoglobine glycosylee (HbAj), tolerance glucidique et donne naissance ä terme ä des enfants de poids normal
devenir neonatal chez les meres presentant un diabete
gestationnel et chez les meres non diabetiques
On a dose l'hemoglobine glycosylee (HbAj) dans trois
groupes de sujets: chez 69 meres non diabetiques ayant
(groupe I), chez 33 meres non diabetiques ayant accouche
ä terme d'enfants macrosomes (> 4000 g) (groupe II), et
chez 51 femmes ayant un diabete gestationnel au cours du
3eme trimestre, les dosages ayant ete effectues avant le
J. Perinat. Med. 12 (1984)
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debut du traitement du diabete (groupe III). Dans tous
les groupes, revaluation diagnostique de la regulation
glucidique a ete effectuee au moyen de Thyperglycemie
provoquee par voie orale au cours de 3 erne trimestre.
L'hemoglobine glycosylee a ete mesuree par Chromato-
graphie d'echange cationique sur petites colonnes ä usage
unique.
Les valeurs moyennes et les deviations standards de
I'HbAi sont de 6,51 ± 0,46 % dans le groupe I, de
6,59 ± 0,42% dans le groupe II et de 7,11 ± 0,56% dans
le groupe III. Entre les valeurs de VHbAi du groupe III
(diabete gestationnel) d'une part et celles des groupes I et
II d'autre part, il v a une difference hautement significa-
tive (p < 0,001;
 x
5
-test).
Des valeurs d'HbAx au-dessus de 7,4% - c'est-ä-dire
au-dessus de x + 2 dsd'HbAj chez les meres non diabeti-
ques - represented une probabilite de 95 % d'anomalie et
indiquent un diabete gestationnel. Les valeurs d'HbAj
comprises entre 7 et 7,4% sont suspectes d'une mauvaise
tolerance glucidique et retrospectivement d'un diabete
gestationnel.
Entre les taux d'HbAj des groupes de non diabetiques et
ceux de groupe de diabetiques il y a une grande zone de
chevauchement. Les valeurs d'HbAj situees dans cette
aire de transition peuvent jetre trouvees ä la fois chez des
patientes non diabetiques et ä la fois chez des patientes
presentant une anomalie de la regulation glucidique.
Les valeurs d'HbAx infenieures ä 6 % elimment un diabete
gestationel et egalement une tolerance glucidique anor-
male avec une probabilite tres elevee.
II n'y a pas de differences remarquables dans 1'etat au
cours du post-partum comme dans le devenir neo-natal
dans les trois groupes explores. Les enfants macrosomes
du groupe II pesent en moyenne un Ig de plus que les
enfants de poids normal du groupe I. Le pourcentage de
cesärienne est deux fois plus eleve que dans le groupe I.
Dans le groupe des diabetiques la moyenne des poids de
naissance est plus elevee de 150 g que celle des enfants de
meres non diabetiques. Les enfants des meres ay ant
presente un diabete gestationel montrent une tendance
accrue ä presenter une hypoglycemie moderee du post-
partum. II est remarquable que dans notre etude les
patientes non selectionnees avec un diabete gestationel
pesent en moyenne 8 ä 9 Kg de plus et sont de 4 a 5 ans
plus ägees que les temoins non diabetiques. Elles on t
requ un traitement etroitement surveille au cours du 3eme
trimestre de la grossesse.
Mots-cles: Devenir neonatal, diabete gestationel, HbAj, hemoglobine glycosylee, hyperglycemie provoquee par voie
orale, macrosomie, poids de naissance, tolerance glucidique.
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